FDA approves brain stem cell transplant

10/21/2005 | San Francisco Chronicle · Wall Street Journal, The

FDA granted permission to doctors at Stanford University Medical Center to transplant immature neural cells into the brains of six children with Batten disease, a degenerative, fatal illness. If approved by an internal Stanford review board, the transplant aims to have the immature cells grow into mature brain cells capable of producing a missing enzyme, a treatment that has shown promise in Batten-afflicted mice. Stem Cells, the biotech firm that developed the treatment, hopes the trial will demonstrate the efficacy and safety of the transplant.

View Full Article in:

San Francisco Chronicle · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT